1. Home
  2. GOCO vs ITRM Comparison

GOCO vs ITRM Comparison

Compare GOCO & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoHealth Inc.

GOCO

GoHealth Inc.

HOLD

Current Price

$1.64

Market Cap

24.5M

Sector

Finance

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.17

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOCO
ITRM
Founded
2001
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.5M
24.3M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
GOCO
ITRM
Price
$1.64
$0.17
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
$5.00
$9.00
AVG Volume (30 Days)
75.5K
1.0M
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
90.82
57.43
EPS
N/A
N/A
Revenue
$798,894,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$947.65
P/E Ratio
N/A
N/A
Revenue Growth
8.74
N/A
52 Week Low
$1.31
$0.14
52 Week High
$13.47
$1.42

Technical Indicators

Market Signals
Indicator
GOCO
ITRM
Relative Strength Index (RSI) 48.30 39.42
Support Level N/A $0.14
Resistance Level $2.53 $0.39
Average True Range (ATR) 0.19 0.01
MACD 0.01 0.00
Stochastic Oscillator 24.65 66.42

Price Performance

Historical Comparison
GOCO
ITRM

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: